MedPath

A Clinical Trial to study the effect of Vatsakadi Vati in management of dyslipdemia

Phase 3
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Registration Number
CTRI/2024/07/070691
Lead Sponsor
RAPodar Ayurvedic college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Both Genders.

2) Age group having 30 to 70 years age.

3)Obese Dyslipidemic and Non-Obese Dyslipidemic Patients (BMI-18.50 to 40.00 kg/m2 as per New

Updated WHO classification of BMI of 2004).

4)Patient having Serum Total Cholesterol Level =200mg/dl

5)Patient having Serum LDL Cholesterol Level =130mg/dl

6)Patient having serum VLDL Cholesterol Level =40 mg/dl

7)Patient having Serum HDL Cholesterol Level =40mg/dl

8)Patient having Serum Triglyceride Level =150mg/dl

Exclusion Criteria

1)Pregnant and lactating mothers.

2)Patients having Diabetes Mellitus.

3)Patients having history of Respiratory Diseases Complications, Coronary Heart Diseases, Renal

Diseases etc.

4)Patients having Acute Complications like Severe Hypertension (B.P 150/90 mm Hg in those with

age 60 and older, and 140/90 mm Hg for adults less than 60 yrs. according to Eighth Joint

National Committee Guideline), Hepatitis or with history of major surgery etc.

5)Patients having disorders like Carcinoma anywhere in the body etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the effect of vatsakadi vati on lipid levels in medodushti w.s.r. to dyslipidaemiaTimepoint: 8 weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To observe the effect on following Parameters <br/ ><br>lipid profile <br/ ><br>1.Total Cholesterol <br/ ><br>2.VLDL <br/ ><br>3.HDL <br/ ><br>4.SR.TRIGLYSERIDES <br/ ><br>5.LDLTimepoint: EVERY MONTHLY FOR 3 MONTHS
© Copyright 2025. All Rights Reserved by MedPath